정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
1857 | Recruiting | CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 | COVID-19 | Drug: Edoxaban Tablets Drug: Colchicine Tablets |
Phase 3 | University Hospital Inselspital, Berne, Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | OTHER | 420 | All | 18 Years | Jessa Ziekenhuis, Hasselt, Belgium Azienda ULSS n.4 "Veneto Orientale", Jesolo, Veneto, Italy ASST Papa Giovanni XXIII, Bergamo, Italy ASST Rhodense, Garbagnate Milanese, Italy Azienda Socio Sanitaria Territoriale di Lecco, Lecco, Italy ASST Grande Ospedal Metropolitano Niguardia, Milan, Italy IRCCS Policlinico San Matteo, Pavia, Italy Azienda Unita' Sanitaria Locale della Romagna, Ravenna, Italy Hospital Clinic de Barcelona, Barcelona, Spain Ospedale regionale Lugano, Lugano, Ticino, Switzerland Bern University Hospital, Bern, Switzerland |
1856 | Not yet recruiting | CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19 | Acute Respiratory Distress Syndrome | Drug: DeltaRex-G | Phase 2 | Aveni Foundation | OTHER | 18 | All | 18 Years ~ 100 Years | |
1855 | Suspended | Coronavirus (COVID-19) ACEi/ARB Investigation | COVID-19 | Drug: Thiazide or Thiazide-like diuretics Drug: Calcium Channel Blockers Drug: ACE inhibitor Drug: Angiotensin receptor blocker |
Phase 4 | National University of Ireland, Galway, Ireland | OTHER | 2414 | All | 60 Years | University Hospital Galway, Galway, Ireland |
1854 | Active, not recruiting | Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization | Acute Kidney Injury | Drug: Sodium bicarbonate Other: Standard of Care |
Phase 4 | West Virginia University | OTHER | 3 | All | 18 Years | WVU Medicine Heart & Vascular Institute, Morgantown, West Virginia, United States |
1853 | Withdrawn | Coronavirus Response - Active Support for Hospitalised Covid-19 Patients | Covid-19 | Drug: Aspirin Drug: Losartan Drug: Simvastatin |
Phase 3 | London School of Hygiene and Tropical Medicine | OTHER | 0 | All | 40 Years | University College Hospital, Ibadan, Oyo, Nigeria Shifa Tameer-e-Millat University, Rawalpindi, Pakistan |
1852 | Withdrawn | Coronavirus Smell Therapy for Anosmia Recovery | Anosmia | Drug: Budesonide Behavioral: High-Concentration Essential Oil Drug: Placebo Behavioral: Low-Concentration Essential Oil |
Phase 2 | Washington University School of Medicine | OTHER | 0 | All | 18 Years ~ 85 Years | Washington University, Saint Louis, Missouri, United States |
1851 | Completed | Corticosteroid Nasal Spray in COVID-19 Anosmia | Anosmia | Drug: mometasone furoate nasal spray | Phase 3 | Benha University | OTHER | 100 | All | 18 Years | Benha University Hospital, Faculty of Medicine, Banh?, Qalubia, Egypt |